Ebola Outbreak in Congo 2026: 87 Dead, No Vaccine for New Strain as Virus Crosses into Uganda

By Editorial Team -

A fast-spreading Ebola outbreak in the DRC's Ituri province has killed at least 87 people across 246 suspected cases — and experts warn the Bundibugyo strain driving it has no approved vaccine.

By One Day MD Editorial Team·Updated May 17, 2026·6 min read
87+Deaths confirmed
246Suspected cases
13Lab-confirmed cases
0Approved vaccines
A deadly Ebola outbreak has been confirmed in the Democratic Republic of Congo (DRC), health authorities announced on May 15, 2026 — and it is already spreading beyond the country's borders. At least 87 people have died and 246 suspected cases have been recorded in Ituri province, eastern DRC, making this the country's 17th Ebola outbreak since the virus was first identified there in 1976.


What makes this outbreak uniquely alarming is the strain involved. Unlike the majority of Congo's previous outbreaks — which were caused by the well-studied Zaire strain — this one has been confirmed as the Bundibugyo strain of Ebola, for which no approved vaccine currently exists.

Where is the outbreak and how did it start?

The outbreak is centred in the health zones of Rwampara and Mongwalu in Ituri province, with additional suspected cases reported in Bunia, the provincial capital. Health officials believe the outbreak began in late April 2026 — meaning the virus had been silently spreading for weeks before confirmation.

The suspected index case is a nurse who died at the Evangelical Medical Centre in Bunia after presenting with fever, severe weakness, vomiting and bleeding — hallmark symptoms of Ebola haemorrhagic fever.

Why late detection matters: "This means we're just learning about this outbreak long after it's already been spreading," one infectious disease expert wrote on X. "This makes it harder to find contacts and all the cases." Ituri is more than 1,000 km from Kinshasa, with poor roads and active conflict — all factors that slow response.

Has Ebola crossed into Uganda?

Yes. On May 14, 2026, a 59-year-old Congolese man died of the Bundibugyo Ebola virus in Kampala, Uganda's capital — confirming the first international spread of this outbreak. Uganda's Ministry of Health confirmed the case was imported from the DRC and said no local transmission had been confirmed as of the latest update.

The case raises serious cross-border concerns. The man travelled by public transport from the DRC to Uganda while symptomatic, potentially exposing multiple people. His body was later transported back across the border to the DRC for burial — another potential transmission event. Africa CDC's director general, Dr Jean Kaseya, stressed the importance of protective equipment during that press conference: "He was sick in this community and he was surrounded by a number of people."

Timeline of key events

  • Late Apr 2026Suspected outbreak begins in Ituri province; index case is a nurse in Bunia.
  • May 5WHO learns of suspected cases; deploys a team to Ituri. Initial field samples test negative.
  • May 14A 59-year-old Congolese man dies in Kampala, Uganda — first cross-border death.
  • May 15Africa CDC officially confirms the outbreak; reports 65 deaths and 246 suspected cases. Bundibugyo strain identified.
  • May 15DRC Health Ministry updates toll to 80 deaths. WHO confirms 13 positive cases; releases $500,000 emergency fund.
  • May 16Death toll rises to at least 87. Africa CDC holds urgent high-level meeting with DRC, Uganda, and South Sudan.

      • Why is the Bundibugyo strain more dangerous to contain?

      The DRC's world-renowned virologist Dr Jean-Jacques Muyembe — who co-discovered Ebola in 1976 — told Reuters that all but one of Congo's 16 previous outbreaks involved the Zaire strain. The identification of the Bundibugyo strain is a significant complication.

      Existing Ebola vaccines and treatments, including the widely used rVSV-ZEBOV (Ervebo) vaccine, were specifically developed to target the Zaire strain. They offer little or no protection against Bundibugyo. This leaves health workers and communities in affected areas without a vaccine shield — making rapid containment through isolation, contact tracing and PPE use even more critical.

      What is the global response?

      Multiple agencies have activated emergency protocols:

      WHO has released $500,000 from its Contingency Fund for Emergencies to support surveillance, contact tracing, lab testing, and clinical care. Director-General Tedros Adhanom Ghebreyesus confirmed 13 total positive cases in a May 15 press briefing.

      Africa CDC convened an urgent high-level meeting with health ministers from DRC, Uganda, and South Sudan, focusing on cross-border surveillance and rapid response deployment.

      US CDC confirmed it is monitoring the outbreak and providing technical assistance to both DRC and Uganda through its in-country offices.

      Direct Relief has donated approximately $40 million in medical aid and 476 tonnes of essential medical supplies and personal protective equipment to regional response partners including Africa CDC.

      What are the biggest risk factors for further spread?

      Africa CDC has flagged several compounding factors that make this outbreak harder to contain than typical ones:

      Active armed conflict: Ituri province is controlled in part by armed groups fighting over the region's mineral wealth. Last week, an attack in the province killed at least 69 people — disrupting healthcare infrastructure and limiting access for response teams.

      Cross-border population movement: Ituri borders both Uganda and South Sudan, areas with significant daily cross-border trade and population movement — as demonstrated by the Uganda fatality.

      Poor infrastructure: The outbreak zone is over 1,000 km from Kinshasa with poor road networks, hampering the rapid deployment of supplies and personnel.

      Late detection: The outbreak had likely been spreading for up to three weeks before official confirmation, giving the virus a significant head start on contact tracers.

    Metabolic Health: Why Risk Is Not Evenly Distributed

    Metabolic health is one of the strongest predictors of infection severity, hospitalization, ICU admission, and mortality across viral outbreaks.

      Key metabolic risk factors

      • Insulin resistance and type 2 diabetes

      • Obesity and visceral adiposity

      • Metabolic syndrome (hypertension, dyslipidemia)

      • Non-alcoholic fatty liver disease (NAFLD)

      Mechanisms linking metabolic dysfunction to worse outcomes

      • Chronic low-grade inflammation (inflammaging)

      • Impaired innate and adaptive immune responses

      • Endothelial dysfunction and microvascular injury

      • Increased viral replication efficiency in hyperglycemic states

      • Higher baseline risk of thrombosis and cytokine dysregulation

      Virus-specific implications

      • COVID-19: Metabolic disease strongly predicts severe disease, ARDS, thrombosis, and long COVID

      • Ebola: Metabolic stress worsens shock tolerance and organ failure

      • Nipah: Metabolic inflammation may amplify neuroinflammatory injury

      • Bird flu: Obesity and insulin resistance increase risk of respiratory failure

      Preventive medicine takeaway: Metabolic optimization is not a lifestyle add-on — it is a front-line pandemic defense strategy that improves outcomes regardless of the pathogen involved.

      Frequently asked questions

      Can the Congo Ebola outbreak spread globally?

      The risk of global spread remains low. Ebola is transmitted through direct contact with bodily fluids — not through air. However, the Uganda case shows cross-border spread is occurring, and health authorities in both countries are conducting active contact tracing.

      Is there a vaccine for the Bundibugyo Ebola strain?

      No approved vaccine currently exists for the Bundibugyo strain. Available vaccines like Ervebo target the Zaire strain. This is a key concern for health responders on the ground.

      How deadly is this outbreak compared to previous ones?

      With 87 deaths among 246 suspected cases, the current case fatality rate exceeds 35% — consistent with historical Bundibugyo outbreaks. For context, the 2018–2020 DRC outbreak (Zaire strain) killed nearly 2,300 people, making it the second largest in history.

      Should travellers to the region be concerned?

      The US CDC and WHO have not issued a "do not travel" advisory as of May 17, 2026, but both urge travellers to the DRC and Uganda to monitor official guidance and avoid contact with anyone showing Ebola symptoms. Check your government's travel advisory page before departure.

      Sources

      Africa Centres for Disease Control and Prevention (Africa CDC) · DRC Ministry of Health · World Health Organization (WHO) · US Centers for Disease Control and Prevention · CNN · NPR · Al Jazeera · Direct Relief · Reuters

Comments

Post a Comment

Popular posts from this blog

Dr Peter McCullough: How to Detox Spike Protein from Body

By Editorial Team -
Image
Base Spike Detox According to Dr Peter McCullough (in a X/Twitter post): Base Spike Detox is what I am currently using in my practice for those who have had COVID-19 multiple times, one or more of the COVID-19 vaccines, or both and believe persistent SARS-CoV-2 Spike protein could be causing problems in their body.  I have arrived, based on the emerging scientific literature (1) and my clinical observation, that three OTC products are essential as a triple base combination: Nattokinase 2000 FU (100 mg) twice a day Bromelain 500 mg once a day Nano/Liposomal Curcumin 500 mg twice a day Related: Nattokinase, Bromelain and Curcumin from The Wellness Company Additional products can be added, including NAC, IVM (Ivermectin), HCQ (Hydroxychloroquine), fluvoxamine, low-dose naltrexone, and blood thinners, depending on the clinical evaluation and the syndrome. The therapeut...
Read more

Dr Peter McCullough: How to Measure Your Spike Protein Antibody (2026)

By Editorial Team -
Image
Dr. McCullough explained (1) that the spike protein is an engineered, synthetic molecule roughly 1,200 amino acids long and resistant to degradation by the body’s normal proteases. He described how the protein was modified in laboratory settings (notably at the Wuhan Institute of Virology) to tightly bind to the ACE2 receptor, which is found throughout the body—in the lungs, heart, endothelium, kidneys, and brain. Because this receptor regulates angiotensin metabolism, older individuals with fewer ACE2 sites catabolize the spike less efficiently, leading to worse outcomes. Whether introduced by infection or by genetic‑code‑based vaccines, McCullough asserted, the persistent spike damages tissues directly and through chronic inflammation, micro‑clotting, and autoimmune cross‑reactivity. He cited more than 300 papers documenting spike deposits in the heart, brain, and vascular tissue, relating these findings to post‑vaccine myocarditis, strokes, and clotting disorders. A chief diagnostic...
Read more

How to Remove Spike Protein from Body: FLCCC I-Recover Protocol

By Editorial Team -
Image
Can you remove spike proteins from your body? Dr. Paul Marik and Dr. Pierre Kory are pleased to introduce the I-RECOVER: Post-Vaccine Treatment protocol, designed to help people who have experienced adverse symptoms after a COVID vaccine. Kory and Marik are both part of the FLCCC*, which was founded in 2020 to share early treatment protocols for COVID-19. Kory is an ICU specialist, triple board certified in internal medicine, critical care and pulmonary medicine. He now runs a private tele-health practice specializing in the treatment of COVID-19, so-called "long-COVID" and post-vaccine syndrome. *The FLCCC Alliance is now the  Independent Medical Alliance Note that there are significant overlaps between the symptoms and features of long COVID/long-hauler syndrome and post-vaccine syndrome. However, a number of clinical features appear to be characteristic of post-vaccine syndrome; most notably, severe neurological symptoms appear to be more common following vaccination. To c...
Read more

Dr Peter McCullough: Povidone Iodine, Oral and Nasal Hygiene (2026)

By Editorial Team -
Image
Dr. Peter McCullough is an internist, cardiologist, epidemiologist, a full professor of medicine at Texas A&M College of Medicine in Dallas, USA. He also has a master's degree in public health and is known for being one of the top five most-published medical researchers in the United States and is the editor of two medical journals. McCullough Protocol 2022 Update: Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections: A Phase 2 Randomized Clinical Trial ( JAMA 2025 ) Everyone is familiar with nasal and oral swab testing for COVID-19. It should be obvious the virus is replicating in the nose, and with Omicron, the speed of replication has become much greater than the prior strains of the virus. Thus, there is a wonderful opportunity to reduce viral replication, in fa...
Read more

Find a Doctor to prescribe Hydroxychloroquine, Ivermectin and Early Outpatient Treatments (2025)

By Editorial Team -
Image
Treatment should start based on clinical suspicion as soon as possible, preferably within the first 3 days of symptoms. Perform PCR testing, but do not withhold treatment pending results. 'Early' treatment will make significant difference in outcome as opposed to late treatment.  Related: How can I get Ivermectin? See the directory of professionals in US below. Directory of Doctors (by State) Prescribing Effective Outpatient COVID-19 Therapy USA ​ MULTIPLE STATES (Telemedicine or online consultation) The Wellness Company ( twc.health ) Medical Specialty: Family Medicine, Functional Medicine Supported Protocols: I-PREVENT (COVID Protection), I-CARE (Early at-home treatment), I-RECOVER (Long COVID and Post-Vaccine treatment) Dr. Miguel Antonatos (IVM) (855) 767-8559  https://text2md.com (States: AL, AZ, CO, FL, GA, IA, ID, IL, KS, KY, MD, ME, MI, MN, MS, ND, NE, NJ, NV, OK, SC, SD, TN, UT, VT, WA, WI, WV) ...
Read more

FLCCC I-Recover Protocol: Post Vaccine Treatment Protocol (2025)

By Editorial Team -
Image
Over the last three years, the COVID-19 pandemic has transformed almost every aspect of our lives before we've had time to stop and question it. Although no official definition exists for post-COVID-vaccine syndrome, a temporal correlation between a patient receiving a COVID-19 vaccine and beginning or worsening of clinical manifestations is sufficient to diagnose as a COVID-19 vaccine-induced injury, when the symptoms are unexplained by other concurrent causes. Dr. Paul Marik and Dr. Pierre Kory are pleased to introduce the I-RECOVER: Post-Vaccine Treatment protocol, designed to help people who have experienced adverse symptoms after a COVID vaccine. Kory and Marik are both part of the FLCCC ( The FLCCC Alliance is now the Independent Medical Alliance ), which was founded in 2020 to share early treatment protocols for COVID-19. Kory is an ICU specialist, triple board certified in internal medicine, critical care and pulmonary medicine. He now runs a priva...
Read more

Front Line Doctors Ivermectin Protocol for Prevention and Treatment of COVID-19 (2025)

By Editorial Team -
Image
The Front Line COVID-19 Critical Care (FLCCC*) Alliance was initially formed as a working group during the early COVID-19 pandemic days in response to multiple early reports of COVID patients with an inexplicably high need for prolonged mechanical ventilation and an excessive death rate.  *The FLCCC Alliance is now the  Independent Medical Alliance Based on rapidly emerging clinical trials evidence, the FLCCC team has developed the   I-MASK+ protocol   ( is now divided into I-Prevent and I-Care protocols ) for prophylaxis and at home treatment of early stage COVID-19. Quercetin, zinc and a number of nutrients and drugs are part of this protocol, not only for critical care but also for prophylaxis and mild disease being treated at home. This article, we will dive deeper to provide the scientific background, related references and rationale of the FLCCC protocols. December 2025 Update: The Stratus Variant (XFG): Symptoms, Global Spread, and Impact in Late 2025 FLCCC ( ...
Read more

Are ‘Turbo Cancers’ Real? Inside the Rise of Early-Onset Cancer (2026)

By Editorial Team -
Image
For years, clinicians and patients have described a disturbing pattern — cancers appearing suddenly, growing at unexpected speed, or diseases thought stable returning aggressively within weeks or months. A sudden rise in younger people with early onset cancers which are more aggressive with more (and unusual) genetic change has been increasingly noted - colorectal, breast and GI tract cancers seem to lead the way. Some called them “turbo cancers”. In oncology, the phenomenon is known as hyper-progression: cancers that accelerate far more rapidly than expected. Early on, these reports were ignored. They surfaced as scattered cases — isolated anecdotes that were easy to dismiss. One of the first to speak publicly was Belgian immunologist Michel Goldman, whose story was published in The Atlantic in 2022. He believed the Covid-19 vaccine may have accelerated his lymphoma. Shortly after vaccination and boosting, he developed swollen lymph nodes, fatigue and night sw...
Read more

Hantavirus Outbreak 2026: Symptoms, Deaths, Human Transmission and What You Need to Know

By Editorial Team -
Image
On 2 May 2026, a cluster of passengers with severe respiratory illness aboard a cruise ship was reported to the World Health Organization (WHO). The vessel was carrying 147 passengers and crew members. As of 4 May 2026, seven cases — including two laboratory-confirmed hantavirus infections and five suspected cases — had been identified. Among these cases were three deaths, one critically ill patient, and three individuals with mild symptoms. Illness onset occurred between 6 and 28 April 2026 and was characterized by fever, gastrointestinal symptoms, rapid progression to pneumonia, acute respiratory distress syndrome (ARDS), and shock. Further investigations remain ongoing. The outbreak response includes coordinated international public health measures such as in-depth epidemiological investigations, case isolation and medical care, patient evacuation, and laboratory testing. Human hantavirus infection is primarily acquired through contact with the urine, feces, or saliva of infected ro...
Read more

Turbo Cancer: Evaluating Claims of Rapid-Onset Malignancies Associated with COVID-19 Vaccination

By Editorial Team -
Image
Abstract The term "turbo cancer" describes purported aggressive, rapidly progressing cancers allegedly induced or exacerbated by COVID-19 vaccines, particularly mRNA formulations. This narrative review synthesizes evidence from observational studies, mechanistic hypotheses, case reports, and counterarguments to assess its validity. A recent 2025 review by Marik and Hope in the Journal of Independent Medicine details epidemiological trends, VAERS data, and proposed mechanisms linking SARS-CoV-2 spike protein to oncogenesis via metabolic reprogramming, immune disruption, and other pathways. Proponents cite associations from large-scale databases, anecdotal reports, and biological plausibility, while critics highlight methodological flaws, biological implausibility, and alternative explanations such as pandemic-related healthcare disruptions. As of October 2025, observational data reveal associations.  While the prognosis of these cancers...
Read more

Labels

Show more